RT @Liferaftgroup: The LRG is actively involved in sharing research findings with the scientific community? Here is a recent publication in…
RT @Liferaftgroup: The LRG is actively involved in sharing research findings with the scientific community? Here is a recent publication in…
RT @Liferaftgroup: LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along…
RT @DrCeSarcoma: Este trabajo tan interesante del @Liferaftgroup y OHSU muestra cómo las sucesivas líneas de tratamiento en pacientes con G…
RT @DrCeSarcoma: This beautiful @Liferaftgroup & @OHSUKnight work shows how the treatment with further tyrosine-kinase inhibitors in #GIST…
RT @DrCeSarcoma: Este trabajo tan interesante del @Liferaftgroup y OHSU muestra cómo las sucesivas líneas de tratamiento en pacientes con G…
RT @DrCeSarcoma: This beautiful @Liferaftgroup & @OHSUKnight work shows how the treatment with further tyrosine-kinase inhibitors in #GIST…
RT @DrCeSarcoma: This beautiful @Liferaftgroup & @OHSUKnight work shows how the treatment with further tyrosine-kinase inhibitors in #GIST…
Este trabajo tan interesante del @Liferaftgroup y OHSU muestra cómo las sucesivas líneas de tratamiento en pacientes con GIST tras el fallo a imatinib incrementa su supervivencia @colectivogist @AEASARCOMA https://t.co/7IaDoHak4k
This beautiful @Liferaftgroup & @OHSUKnight work shows how the treatment with further tyrosine-kinase inhibitors in #GIST after #imatinib failure increases overall survival #CureSarcoma #Sarcoma https://t.co/7IaDoHak4k
RT @TJH43: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitor…
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Lif... - PubMed - NCBI https://t.co/Wl4dXbV0oW
RT @Liferaftgroup: LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along…
RT @Liferaftgroup: LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along…
RT @Liferaftgroup: LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along…
LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along with Dr. Michael Heinrich of OHSU, have published a study on the impact of treatments beyond first line in #GIST on #Overallsurvival. ht